在粉样蛋白积累和认知衰退之间发生的潜在变化-变化
Hannah M Klinger1, Brian C Healy1, Bernard J Hanseeuw2,3
1Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|October 29, 2024
概括
在β-粉样蛋白 (Aβ) 积累的短期变化预测健康的老年人认知能力下降. 这种关系可能比以前理解的要强,可能会掩盖病理学的影响.
科学领域:
- 神经科学是一个神经科学.
- 老年学是一门学科.
- 生物医学成像技术 生物医学成像技术
背景情况:
- 已知横截面β-粉样蛋白 (Aβ) 对认知的影响.
- 需要进一步探索Aβ和认知之间的纵向变化变化关系.
研究的目的:
- 研究Aβ变化与认知功能之间的纵向关系.
- 为了确定Aβ积累是否预测临床正常的老年人认知能力下降.
主要方法:
- 双变潜变得分模型 (LCSM) 分析了C-匹兹堡化合物-B (PiB) PET和临床前阿尔茨海默氏症认知复合-5 (PACC-5) 的变化.
- 我们使用了哈佛老年大脑研究 (HABS) 中352名健康老年人的数据,使用了长达9年的PiB-PET和PACC-5数据.
- 模型根据包括年龄,性别,Apolipoprotein ε4 (APOEε4) 状态和中叶 (MTL) tau-PET负担在内的共变量进行调整.
主要成果:
- Aβ积累与随后的认知衰退有显著的关联,独立于横截面的Aβ负担.
- 在对共变量进行调整后,没有发现横截面tau-PET和认知拦截/斜率之间的显著关联.
- 对Aβ和认知变化的潜在变化模型可能会掩盖MTL tau的影响.
结论:
- 在Aβ积累的短期变化与正常衰老中的认知衰退有关.
- Aβ积累是认知衰退的关键预测因素,但不是唯一的因素.
- 这项研究表明,Aβ变化动态在预测认知变化方面可能比横截面Aβ或MTL tau更有影响力.
相关概念视频
Alzheimer's Disease: Overview
449
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
449
Cognitive Development During Adulthood
61
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
61
Alzheimer's Disease: Treatment
165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165
Dementia
97
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
97
Amyloid Fibrils
9.3K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.3K
Long-term Depression
2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.5K


